IP Library › Assignment 066541/0988
Patent Assignment
Reel/Frame 066541/0988

Change of Name

Recorded: 2024-02-23 Pages: 2
Assignor
KEMPHARM DENMARK A/S
Executed: 2023-07-05
Assignee
ZEVRA DENMARK A/S
OLE MAALØES VEJ 3, COPENHAGEN N, 2200, DENMARK
Covered Properties (2)
Arimoclomol Formulation
Application: 15/511,094 →
Publication: US 2017/0239232
Arimoclomol Formulation
Application: 16/826,733 →
Publication: US 2020/0261437
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 28, 2017
From: HINSBY, ANDERS MORKENBERG; JENSEN, THOMAS KIRKEGAARD; BOLWIG, GERT MADS; CAMOZZI, CARLOS ROBERTO
To: ORPHAZYME APS
Reel/Frame 043729/0167 →
Assignment of Assignor's Interest May 24, 2020
From: HINSBY, ANDERS MØRKEBERG; JENSEN, THOMAS KIRKEGAARD; BOLWIG, GERT MADS; CAMOZZI, CARLOS ROBERTO
To: ORPHAZYME A/S
Reel/Frame 052740/0226 →
Assignment of Assignor's Interest Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →